Success Story: Extraordinary Ability in Artificial Intelligence Recognized with EB-1A Approval in 19 Days
Client’s Testimonial:
"Thank you so much for your kind message and, most importantly, for all of your help throughout my EB1A case. I am truly grateful to the entire team for your professional, efficient, and thorough work. Your clear instructions, detailed guidance, patience, and prompt support made a difficult process much more manageable.”
On July 27th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for an Assistant Professor in the Field of Artificial Intelligence (Approval Notice).
General Field: Artificial Intelligence
Position at the Time of Case Filing: Assistant Professor
Country of Origin: China
Approval Notice Date: July 27th, 2026
Processing Time: 19 days (Premium Processing Requested)
Case Summary:
Artificial intelligence is transforming biomedical research by enabling scientists to interpret increasingly complex biological data with greater accuracy and efficiency. The client's work focuses on developing advanced machine learning methods for multi-omics data integration, disease module discovery, and cancer driver identification, helping researchers improve disease prediction, identify therapeutic targets, and support precision medicine. These innovations have influenced both artificial intelligence and biomedical research by making sophisticated computational analyses more interpretable and applicable to real-world healthcare challenges.
The petition demonstrated the client's sustained record of achievement through objective evidence, including:
- 17 peer-reviewed journal articles, 7 peer-reviewed conference papers, and 2 preprints.
- 941 Google Scholar citations, placing the client among the top 1% most highly cited Computer Science researchers over the past ten years.
- At least 56 completed peer reviews for leading journals.
- Funding from the National Science Foundation.
The petition also emphasized that the client's influence extends well beyond standard publication metrics. Researchers around the world have actively incorporated the client's artificial intelligence methods into subsequent studies involving complex data integration, predictive disease modeling, and advanced machine learning for biomedical applications. These independent uses demonstrated that the client's research has become a valuable foundation for ongoing scientific advances rather than remaining isolated academic contributions.
North America Immigration Law Group (Chen Immigration Law Associates) organized the petition to present these accomplishments as evidence of sustained national and international recognition, showing that the client's scholarly influence, professional service, competitive research funding, and original contributions collectively satisfied the EB-1A standard for extraordinary ability. As one independent expert noted:
"His work not only advances our understanding and analysis of complex biomedical data but also holds transformative potential for the future of medical diagnostics, drug discovery, and personalized treatment in this country."
USCIS approved the petition on July 27, 2026, after just 19 days of Premium Processing. We are honored to have assisted this exceptional researcher in establishing extraordinary ability, and we wish the client continued success in pioneering artificial intelligence innovations that advance biomedical science and precision healthcare.